EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Validation of a National Pediatric HIV Risk Screening Tool at 31 Health Facilities in Zambia

Hannah M. Canepa, Amy Medley, Steve Gutreuter, Helen Connolly, Megumi Itoh, Tiffiany Aholou, Elizabeth Rabold, Lindsey Torre, Kennedy Nkwemu, Edgar Chisuwo, Francis Haamuleya, Catherine Lungu, Moono Hansombo, Rob Nelson, Natalie Vlahakis, Tina Chisenga, Lloyd Mulenga, Levi Mbulo, Jessica Gross

Pediatric Infectious Disease Journal · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background: To improve testing efficiency, Zambia introduced a national pediatric human immunodeficiency virus (HIV) Risk Screening Tool (HRST) in 2019. However, concerns about its sensitivity led to its suspension in 2021 pending formal evaluation. We therefore undertook a formal validation of this tool to assess its diagnostic performance. Methods: We conducted a cross-sectional evaluation from February 2021 to March 2022 in 31 health facilities across Lusaka, Southern and Western Provinces. Children aged 2–14 years were screened using the HRST, and all subsequently underwent HIV testing to estimate the tool’s sensitivity and specificity. L1-regularized logistic regression was used to identify the most predictive screening questions to develop an optimized tool. Focus group discussions with 85 healthcare providers explored implementation experiences. We also estimated unit costs for HRST-based screening and universal testing and compared these with published cost estimates for provider-assisted HIV self-testing. Results: Among 15,431 children tested, 90 (0.58%) were HIV-positive. The 6-question HRST demonstrated 80.0% sensitivity and 71.0% specificity. An optimized 4-question tool showed similar performance (77.8% sensitivity, 73.2% specificity). Providers reported that the HRST supported targeted testing and workflow efficiency, but highlighted challenges related to consent, disclosure and caregiver knowledge. Estimated unit costs per child tested were $2.25 for universal testing, $0.39 for HRST-based screening and $3.08 for HIV self-testing. Conclusion: Although the HRST improves testing efficiency, its moderate sensitivity underscores the risk of missed diagnoses when used alone. Cost and implementation findings support a differentiated pediatric HIV testing strategy that deploys universal testing, risk-based screening, or HIV self-testing based on local capacity and resource constraints.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Hannah M. Canepa, Amy Medley, Steve Gutreuter, Helen Connolly, Megumi Itoh, Tiffiany Aholou, Elizabeth Rabold, Lindsey Torre, Kennedy Nkwemu, Edgar Chisuwo, Francis Haamuleya, Catherine Lungu, Moono Hansombo, Rob Nelson, Natalie Vlahakis, Tina Chisenga, Lloyd Mulenga, Levi Mbulo, Jessica Gross
Quelle
Pediatric Infectious Disease Journal
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0891-3668, 1532-0987
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Hannah M. Canepa, Amy Medley, Steve Gutreuter, Helen Connolly, Megumi Itoh, Tiffiany Aholou, Elizabeth Rabold, Lindsey Torre, Kennedy Nkwemu, Edgar Chisuwo, Francis Haamuleya, Catherine Lungu, Moono Hansombo, Rob Nelson, Natalie Vlahakis, Tina Chisenga, Lloyd Mulenga, Levi Mbulo, Jessica Gross (2026). Validation of a National Pediatric HIV Risk Screening Tool at 31 Health Facilities in Zambia. Pediatric Infectious Disease Journal. https://doi.org/10.1097/inf.0000000000005401
RIS BibTeX CSL-JSON